Table 3. Comparison between survivors and non-survivors.
| Survivor (n = 150) | Non-survivor (n = 19) | P-value | |
|---|---|---|---|
| Age (year) | 53.9±16.8 | 53.6±19.6 | 0.944 |
| Sex (male) | 98 (65.3%) | 14 (73.7%) | 0.468 |
| Injury severity score (ISS) | 10 (1–50) | 25 (9–50) | <0.001 |
| Injury severity score (ISS) > 15 | 62 (41.3%) | 16 (84.2%) | <0.001 |
| Associated injury (AIS ≥3) | 45 (30%) | 12 (63.2%) | 0.004 |
| Shock | 35 (23.3%) | 12 (63.2%) | <0.001 |
| Initial WBC (/mm3) | 12254±5670 | 10558±7514 | 0.353 |
| Initial DNI (%) | 0.45 (0–44.7) | 3.3 (0–52.8) | 0.053 |
| Initial CRP (mg/dL) | 0.29 (0–30.10) | 0.29 (0.29–23.80) | 0.215 |
| Initial Lactate (mmol/L) | 3.04±2.23 | 9.00±4.10 | <0.001 |
| GI perforation | 57 (38.0%) | 5 (26.3%) | 0.319 |
| Solid organ injury | 38 (25.3%) | 10 (52.6%) | 0.013 |
| SOFA score on ICU admission | 3 (0–15) | 9.5 (6–18) | <0.001 |
| Postoperative shock | 12 (8.0%) | 18 (94.7%) | <0.001 |
| Postoperative WBC (/mm3) | 11096±5091 | 7161±5139 | 0.002 |
| Postoperative DNI (%) | 3.3 (0–41.2) | 9.0 (2.3–48.8) | 0.009 |
| Postoperative CRP (mg/dL) | 0.32 (0–26.40) | 0.29 (0–13.70) | 0.921 |
| Postoperative lactate (mmol/L) | 2.82±1.73 | 7.64±3.54 | <0.001 |
| POD1 WBC (/mm3) (n = 163) | 9846±3620 | 7017±3949 | 0.005 |
| POD1 DNI (%) (n = 162) | 1.5 (0–35.9) | 17.0 (1.4–57.0) | 0.001 |
| POD1 CRP (mg/dL) (n = 153) | 10.40 (0–35.80) | 2.80 (0–17.30) | 0.014 |
| POD2 WBC (/mm3) (n = 158) | 8695±3080 | 5561±3972 | 0.001 |
| POD2 DNI (%) (n = 157) | 0.8 (0–52.9) | 27.9 (0–62.1) | 0.004 |
| POD2 CRP (mg/dL) (n = 145) | 15.20 (0–35.10) | 7.32 (0–32.1) | 0.013 |
| ICU stay (day) | 4 (1–90) | 3 (1–58) | 0.450 |
| Duration of hospitalization (day) | 21 (2–697) | 3 (1–58) | <0.001 |
AIS, abbreviated injury scale; WBC, white blood cell; DNI, delta neutrophil index; CRP, C-reactive protein; SOFA, sequential organ failure assessment; POD, postoperative day; ICU, intensive care unit.